Luckily, inasmuch as high-risk V3-positive and/or TP53-mutated cases need closer monitoring, they also have a higher number and higher abundance (variant allele frequencies) of molecular alterations in the blood circulating tumor DNA (ctDNA), which can be used for remission tracking and earlier identification of treatment failure [72,91]. Here, TP53 is linked to neoplasm.